Article Details
Retrieved on: 2021-04-05 14:26:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Morgan Stanley raised their stock price forecast on Accolade to $60 from $57, reiterating an “Overweight” rating on the health technology company ...
Article found on: www.fxempire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here